This is a kind of silly question but hope somebody can help me out here. When people do NGS, do they need to spike in controls? Can someone maybe direct me to a few papers on this?
Thanks a lot!
Thanks a lot!
-
-
I haven't heard of anyone spiking in controls, though perhaps in a few less common pipelines it is used. As far as I know it's not used for RNA-Seq, SNP calling, genome assembly or ChIP-Seq. The controls most people use are simply a control condition, e.g. untreated cells for RNA-Seq, wild type for SNP calling, different IgG pull-downs for ChIP-Seq (there was some discussion about these earlier). I'm not sure what you could use as a control for genome assembly, but it may or may not require one.
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment